Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-25-082448

Director acquired 10,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stenhouse Mark Director 2025-06-03 Grant or award +10,500 30,000 D
Derivatives
Stenhouse Mark Director 2025-06-03 Grant or award · Stock Option (Right to Buy) +17,500 17,500 D
Loading xslF345X05/ownership.xml…